Switch without the product changing.
Move your formula to a lab built to scale it.
Some brands come to us because they have outgrown the manufacturer that launched them. Others come because that relationship went wrong. Either way the worry is the same: moving an existing product to a new lab without it coming out different, and without supply going dark in the middle.
Technology transfer is a defined, visible process here, and you approve every sample before anything scales.
Why Brands Move to Us
Most transfers start from one of a few places. A brand has grown into volume its current manufacturer cannot hold, or quality drifts as the runs get bigger.
A move into Ulta, Sephora, or a new market brings documentation and compliance requirements the current partner cannot meet.
A founder wants real protection for the formula the brand is built on, or a clearer path to owning it.
Sometimes the relationship has simply stopped being a partnership.
We are not here to disparage another lab. We are here to make the move worth it: a serious formulation and manufacturing partner, with the systems to scale prestige skincare and the discipline to protect it.
What a Transfer Is
A technology transfer moves an existing, finished formula and its process to us to manufacture. It is different from new product development, where we formulate from a brief. If you have a formula, a process, and documentation, that is a transfer.
If you want us to match or reverse-engineer a product you do not have the formula for, that is closer to new development, and we will tell you so up front and scope it that way.
One brief per product captures the current state: the formula, the process, the documentation, the markets you sell in, and the packaging. From there, our R&D, Regulatory, QA/QC, Operations, and Finance leads each assess the transfer before we commit, so what we promise is what we can deliver.
How the Transfer Works
The fear with any transfer is that the formula will not come out the same, or that supply will lapse while it moves. The process is built to answer both.
We replicate, then you approve.
Our lab works from your formula and process and reproduces it, and every trial passes a compliance gate: ingredients are checked against your markets, your clean standard, and applicable regulations before the formula advances. You review and approve samples against agreed match criteria, side by side with your current product, before anything scales.
You can see where it is.
Your project runs on our stage-gated tracker. Each stage has a named owner, status updates in real time, and you are kept informed as the work moves, instead of waiting in the dark during a vulnerable migration.
We sequence it so supply does not lapse.
Where continuity matters, we plan the timeline around it, so you can keep ordering from your current manufacturer until our validation batches are approved and production is ready. The goal is a switch with no gap, not a leap.
Then we scale it properly.
Pilot and validation batches, stability re-testing where needed, and your approval gates come before full production, so scale-up is controlled, not improvised.
Your Formula Is Protected From the First Conversation
Moving a formula means handing it to someone new, so the protection has to be real before any data moves.
A mutual NDA goes in place before formula data is shared. Access is controlled, your formula and project data stay under one owned US roof with US data residency and batch-level lot tracking, and your formula is never shared with affiliated brands or reused in anything we make for ourselves or anyone else. [non-use terms pending verification]
The formula you bring is yours, and stays yours. We identify up front what transfers as your formula, what stays our background know-how, and how any process improvements we make are handled, so there are no surprises later. [ownership terms pending verification]
The protection is written down, not promised.
What You Bring
The more complete the picture, the cleaner the transfer. A typical transfer starts with:
- Your formula or current documentation: the master formula card or bill of materials, with INCI, trade names, and suppliers where you have them.
- Process and specifications: batch or manufacturing instructions, release specs, and analytical or test methods.
- Stability and safety data: existing stability and shelf life, preservative-efficacy results, and SDS or regulatory documentation, plus OTC documentation if the product is a drug.
- Markets and standards: where the product is sold, your clean standard or restricted-ingredient list, and an allergen list if it sells outside the US.
- Packaging and samples: packaging and label specs, and reference samples of the current product.
- Current volumes and timing: your run size today and the date you need first production.
If some of this is missing, that is normal, and part of what the consult sorts out. We work from what you have.
Built to Carry You Into Retail
A transfer is only an upgrade if the new lab can take the brand where it is going.
We are ISO 22716 certified for cosmetic GMP, third-party audited, and manufacture to cGMP for OTC drug products, with facility registration current under MoCRA. We formulate to meet the regulatory requirements of the markets you sell in, including the US, Canada, EU, ASEAN, Australia, China, and Mercosur.
We coordinate regulatory registration directly in the US and Canada. For other markets, we support registration in partnership with a local regulatory representative in that region.
Production capacity sits well above where most growing brands are today, with real headroom to scale into retail volume.
Sun care and other OTC products stay in their lane, built to the applicable framework, with SPF, broad-spectrum, and other drug-lane claims tested through qualified third-party labs.
Bring us the product you need to move.
Bring your current formula, your documentation, or just the problem with where it is made now. We will map the match plan, the timeline, the protection, and what it takes to scale it, with the chemists directly. The consult is where specific case histories come out, under NDA.